• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗高血压治疗的应答者与无应答者。

Responders and non-responders to antihypertensive treatment.

作者信息

Bulpitt C J

机构信息

University of London, Hammersmith Hospital.

出版信息

Drugs. 1988;35 Suppl 6:142-6. doi: 10.2165/00003495-198800356-00019.

DOI:10.2165/00003495-198800356-00019
PMID:3042353
Abstract

Responders to antihypertensive treatment have been defined as any patient with a fall in mean arterial pressure, however small; any patient with a fall in mean arterial pressure of 5%, 10% or greater; and any patient achieving a goal blood pressure, usually a diastolic pressure less than 90 mm Hg. Non-responders are normally defined as those who do not fit into the category of a responder. Blood pressure, however, varies considerably during follow-up, and diastolic pressure has a within-subject standard deviation of 8 mm Hg. Blood pressure varies according to environmental factors such as temperature, diet and stress, and tends to drift downwards during follow-up as the patient becomes accustomed to having blood pressure taken, to the place of measurement and to the observer. In a statistical sense, responders may be defined as the 2.5% with a fall in DBP greater than 16 mm Hg, yet in clinical studies of a low sodium diet reports have indicated that 50% have experienced an increase in pressure and 50% a fall (responders). Although the characteristics of those with a fall in pressure are of interest and should be compared with those who do not respond, a 50:50 division is unlikely to help. Methods of identifying true responders and non-responders are discussed in this brief review, along with the errors that may arise from a misclassification and problems of conducting further trials of treatment on the non-responders.

摘要

抗高血压治疗的有效者被定义为任何平均动脉压下降的患者,无论下降幅度多小;平均动脉压下降5%、10%或更多的任何患者;以及任何达到目标血压的患者,通常是舒张压低于90毫米汞柱。无反应者通常被定义为不符合有效者类别的患者。然而,在随访期间血压变化很大,舒张压的个体内标准差为8毫米汞柱。血压会根据温度、饮食和压力等环境因素而变化,并且在随访期间往往会随着患者逐渐习惯测量血压、测量地点和测量者而下降。从统计学意义上讲,有效者可定义为舒张压下降超过16毫米汞柱的2.5%的患者,但在低钠饮食的临床研究中,报告显示50%的患者血压升高,50%的患者血压下降(有效者)。尽管血压下降者的特征令人关注,应该与无反应者进行比较,但50:50的划分不太可能有帮助。本简要综述讨论了识别真正有效者和无反应者的方法,以及错误分类可能产生的误差和对无反应者进行进一步治疗试验时存在的问题。

相似文献

1
Responders and non-responders to antihypertensive treatment.抗高血压治疗的应答者与无应答者。
Drugs. 1988;35 Suppl 6:142-6. doi: 10.2165/00003495-198800356-00019.
2
Responders to antihypertensive treatment: how may they be identified?抗高血压治疗的反应者:如何识别他们?
J Hypertens Suppl. 1988 Dec;6(2):S31-5.
3
[Blood pressure response to antihypertension treatment. Comparison of data obtained at the doctor's office and by ambulatory blood pressure measurement].
Arch Mal Coeur Vaiss. 1989 Oct;82(10):1733-7.
4
[Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].老年患者中难以控制的动脉高血压。“白大衣效应”的意义
Rev Port Cardiol. 1999 Oct;18(10):897-906.
5
Benazepril at incremental doses in essential hypertension.
Int J Clin Pharmacol Ther Toxicol. 1990 Feb;28(2):63-6.
6
A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.一项比较哌唑嗪控释片与依那普利治疗糖尿病高血压患者的随机、对照、多中心研究。孟买高血压研究组。
J Assoc Physicians India. 1998;Suppl 1:52-62.
7
Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.高血压且血脂正常患者中多单位控释哌唑嗪与阿替洛尔的比较:一项随机对照多中心研究。海得拉巴高血压研究组
J Assoc Physicians India. 1998;Suppl 1:41-51.
8
Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial.基于家庭或医生办公室血压测量的降压治疗:一项随机对照试验。
JAMA. 2004 Feb 25;291(8):955-64. doi: 10.1001/jama.291.8.955.
9
Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators.基于常规或动态血压测量的降压治疗。一项随机对照试验。动态血压监测与高血压治疗研究人员。
JAMA. 1997 Oct 1;278(13):1065-72.
10
Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring.老年高血压患者使用缓释非洛地平实现血压平稳控制:通过24小时动态血压监测进行评估
Drugs Aging. 2002;19(7):541-51. doi: 10.2165/00002512-200219070-00007.

引用本文的文献

1
The Effect of Kyolic Aged Garlic Extract on Gut Microbiota, Inflammation, and Cardiovascular Markers in Hypertensives: The GarGIC Trial.蒜素老年大蒜提取物对高血压患者肠道微生物群、炎症及心血管标志物的影响:大蒜干预高血压心血管疾病(GarGIC)试验
Front Nutr. 2018 Dec 11;5:122. doi: 10.3389/fnut.2018.00122. eCollection 2018.
2
The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: the AGE at Heart trial.aged大蒜提取物对未控制高血压患者血压及其他心血管危险因素的影响:“心脏的AGE”试验
Integr Blood Press Control. 2016 Jan 27;9:9-21. doi: 10.2147/IBPC.S93335. eCollection 2016.

本文引用的文献

1
A note on the analysis of repeated measurements of the same subjects.关于同一受试者重复测量分析的一则注释。
J Chronic Dis. 1962 Oct;15:969-77. doi: 10.1016/0021-9681(62)90116-9.
2
Factors influencing blood pressure in salt-sensitive patients with hypertension.影响盐敏感性高血压患者血压的因素。
Am J Med. 1980 Sep;69(3):334-44. doi: 10.1016/0002-9343(80)90002-9.
3
Evidence for altered vascular reactivity in sodium-sensitive young subjects with borderline hypertension.钠敏感性临界高血压年轻受试者血管反应性改变的证据。
Am J Med Sci. 1984 Sep;288(2):65-73. doi: 10.1097/00000441-198409000-00004.
4
Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension.轻度原发性高血压患者对适度限钠及补钾的血压反应
Lancet. 1984 Apr 7;1(8380):757-61. doi: 10.1016/s0140-6736(84)91276-5.
5
The Australian therapeutic trial in mild hypertension. Report by the Management Committee.澳大利亚轻度高血压治疗试验。管理委员会报告。
Lancet. 1980 Jun 14;1(8181):1261-7.
6
The variability of measurements of casual blood pressure. I. A laboratory study.
Clin Sci. 1966 Apr;30(2):325-35.
7
Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.哌唑嗪治疗高血压:与甲基多巴和安慰剂的双盲评估。
Curr Ther Res Clin Exp. 1974 Aug;16(8):769-77.
8
Heterogeneity of blood pressure response to dietary sodium restriction in normotensive adults.血压正常成年人对饮食中钠限制的血压反应异质性。
J Chronic Dis. 1987;40(3):245-50. doi: 10.1016/0021-9681(87)90160-3.
9
Ketanserin--a new antihypertensive agent.
J Hypertens Suppl. 1986 Apr;4(1):S13-6.
10
MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.医学研究委员会轻度高血压治疗试验:主要结果。医学研究委员会工作组
Br Med J (Clin Res Ed). 1985 Jul 13;291(6488):97-104. doi: 10.1136/bmj.291.6488.97.